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Abstract 
Mycoplasma haemocanis (Mhc) and ‘Candidatus Mycoplasma haematoparvum’ 
(CMhp) are canine haemoplasma species that can induce anaemia in 
immunocompromised and/or splenectomised dogs. This study aimed to determine the 
prevalence and phylogeny of canine haemoplasma species in dogs from Nigeria and 
describe any risk factors for infection. Canine haemoplasma species-specific and 
generic haemoplasma qPCR assays were used. The species-specific qPCR assays 
found Mhc infection in 18 of 245 dogs (7.3%), and CMhp infection in only one dog 
(0.4%). The generic haemoplasma qPCR assays were positive in 44 of 245 (17.9%) 
dogs. Twenty-five dogs had discordant qPCR results in that they were generic 
haemoplasma qPCR positive but species-specific qPCR negative. Further evaluation 
of these dogs by 16S rDNA sequencing gave limited results but 5 were confirmed to 
be infected with non-haemoplasma species: 2 Anaplasma phagocytophilum, 1 
Anaplasma ovis, 1 Serratia marcescens and 1 Aerococcus spp. The 16S rRNA gene 
sequences from Mhc species showed >99.8% identity with each other and >99.6% 
identity with GenBank sequences, and resided in a single clade with other global Mhc 
and Mycoplasma haemofelis sequences, indicating low 16S rRNA genetic variability 
amongst this canine haemoplasma species. 
 
Keywords: haemoplasmas, Nigeria, dogs, prevalence, risk factors  
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1.1 Introduction 
Haemoplasmas are small bacterial haemotropic mycoplasmas that parasitize 
the surface of erythrocytes in a wide range of mammal species (Messick, 2004). Dogs 
are mainly infected with two haemoplasma species: Mycoplasma haemocanis (Mhc) 
and ‘Candidatus Mycoplasma haematoparvum’ (CMhp). Infections are usually 
chronic and subclinical in immunocompetent dogs but may lead to clinical signs 
related to haemolytic anaemia following splenectomy, immunosuppression or 
concurrent infections (Messick et al., 2002; Sykes et al., 2005). 
Both Mhc and CMhp have been reported in dogs from Spain (Novacco et al., 
2010; Roura et al., 2010), Trinidad (Barker et al., 2010), France (Kenny et al., 2004), 
Switzerland (Wengi et al., 2008), Portugal (Novacco et al., 2010), Italy (Novacco et 
al., 2010), Japan (Sasaki et al., 2008), United States (Compton et al., 2012), Greece 
(Tennant et al., 2011) and Australia (Barker et al., 2012; Hetzel et al., 2012). Previous 
studies (Kenny et al., 2004; Novacco et al., 2010) reported that dogs from warm 
subtropical climates may be at a higher risk of haemoplasma infection due to the 
concurrent presence of ectoparasites, such as Rhipicephalus sanguineus, which have 
been proposed as vectors (Kenny et al., 2004). However, data confirming vector 
transmission of canine haemoplasmas are lacking and little information exists 
regarding risk factors for canine haemoplasma infection in dogs from warmer tropical 
climates such as Africa and South America.  
Recently, a study reported a high level of tick-borne pathogens such as 
Hepatozoon canis, Ehrlichia canis, Rickettsia spp., Babesia rossi and Anaplasma 
platys in two genera of ticks, Rhipicephalus and Heamaphysalis, in dogs from 
Nigeria, Africa (Kamani et al., 2013). Although haemoplasmas have been found in 
African dogs from Tanzania (Barker et al., 2010) and Sudan (Inokuma et al., 2006), 
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no study has evaluated haemoplasma prevalence in dogs from Nigeria (Kamani et al., 
2013). 
The aim of this study was to investigate any correlation between haemoplasma 
infection and potential risk factors in dogs. Additionally, we also assessed the 
prevalence of haemoplasmas in dogs from Nigeria using qPCR assays, and 
molecularly characterized the 16S rRNA gene of the identified haemoplasma species.  
 
1.2 Materials and Methods 
1.2.1 Recruitment and data collection 
Blood (EDTA) samples were obtained from dogs presenting to veterinary 
clinics in the city of Jos, Plateau State, Nigeria and from samples submitted to the 
Parasitology Division Laboratory, National Veterinary Research Institute, Vom, 
Nigeria. Packed cell volume (PCV) was determined on samples by the 
microhaematocrit centrifugation method, with anaemia defined as a PCV < 35%. 
Samples were stored at 4ºC and subsequently shipped to School of Veterinary 
Sciences, University of Bristol, UK for molecular analysis. Data regarding age, 
gender (including neutering status), breed, whether the dog was privately owned or 
from a breeding kennel, clinical health status (healthy or sick, based on the dog’s 
history and clinical examination), presence of ticks, ectoparasite prophylaxis, 
splenectomy history and travel history was collected when available for each dog. 
 
1.2.2 DNA extraction 
A QIAxtractor was used to extract DNA from 100µl of EDTA blood using the 
DX reagent kit (Qiagen) as per the manufacturer’s protocol. The DNA was eluted in 
100µl elution buffer and stored at -20ºC until use. Two negative controls using 
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phosphate buffered saline were performed in parallel with the extraction of every set 
of 94 canine samples. 
 
1.2.3 Species-specific haemoplasma qPCR assay 
The samples were subjected to species-specific qPCRs for Mhc and CMhp, as 
previously described (Barker et al., 2010). Each assay was duplexed with a canine 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) qPCR as an internal control to 
demonstrate the presence of amplifiable DNA and the absence of PCR inhibitors; a 
threshold cycle (Ct) of 26 was used as a cut off, above which the samples underwent 
repeat DNA extraction and repeat qPCR analysis. In each run of 94 samples, DNA 
from a known haemoplasma positive dog was used as a positive control and water as 
a negative control. 
 
1.2.4 Generic haemoplasma qPCR assay 
The samples also underwent previously described (Tasker et al., 2010) generic 
haemoplasma qPCR assays designed to detect novel haemoplasma species. These 
generic qPCR assays comprised two assays that amplify 16S rRNA gene sequences of 
the two main groups of haemoplasma species: the so-called haemominutum (HM) and 
haemofelis (HF) groups. These assays should detect any infecting haemoplasma 
species that would not be detected by the Mhc and CMhp specific qPCRs due to 
differences in their primer or probe binding sites. The protocol was adapted as 
follows: 12.5µL of 2X Promega GoTaq Hot Start Colorless Master Mix (UK) with 
0.2µM of each primer, 0.1µM probe, 4.5mM MgCl2 final concentration and 5µl of 
DNA template with water to 25µL. All qPCRs were performed in Agilent MX3005P 
(Agilent, UK) thermocycler with initial incubation of 95ºC for 2 minutes followed by 
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45 cycles of 95ºC for 10 seconds and 60ºC for 30 seconds during which the 
fluorescence data were collected. In each batch of 94 qPCRs, DNA from known 
haemoplasma infected dog was used as a positive control, and water as a negative 
control. 
 
1.2.5 Conventional PCRs and 16S rRNA gene sequencing 
All dogs with discordant qPCR results (positive by the generic qPCRs but 
negative by the species-specific qPCRs) were submitted to two different conventional 
PCRs to amplify the near complete 16S rRNA gene and to perform DNA sequencing. 
The first conventional PCR amplified ≅1400bp from the 16S rRNA gene and utilised 
16S rRNA gene universal primers (8F and 1492R) as previously described (Pitulle 
and Pace, 1999). The reaction included 12.5µl of HotstarTaq Master mix with 0.2 µM 
of each primer, 3.0mM of MgCl2 and 5µl of DNA template with water to a final 
volume of 25 µL. The reaction was performed in a SureCycler 8800 thermal cycler 
(Agilent Technologies, USA) with cycling conditions as follows: 95ºC for 15 minutes 
followed by 45 cycles of 95ºC for 15 seconds, 48ºC for 30 seconds, 72ºC for 2 
minutes, and a final extension of 72ºC for 10 minutes. The second conventional PCR 
amplified ≅1100bp from the 16S rRNA gene of Mycoplasma haemofelis (Mhf)/Mhc 
and ‘Candidatus Mycoplasma haemominutum’ (CMhm)/CMhp using previously 
described 16S rRNA gene species-specific primers (MhfFw2 and MhfRev2; 
CMhmFw2 and CMhmRev2 respectively) (Aquino et al., 2014). This reaction 
comprised 12.5 µL of 2X Promega GoTaq® Hot Start Colorless Master Mix (UK) 
with 0.2 µM of each primer and 1 µL of DNA template with water to a final volume 
of 25 µL. The reaction was performed in a SureCycler 8800 thermal cycler (Agilent 
Technologies, USA) with cycling conditions as follows: 95ºC for 5 minutes, followed 
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by 45 cycles of amplification (95ºC, 10 seconds; 62ºC, 30 seconds; 72ºC, 90 seconds) 
with final extension of 72ºC for 5 minutes. Samples known to be positive for Mhc and 
Mhf were used as positive controls for the MhfFw2 and MhfRev2 primers and CMhp 
and CMhm positive samples were used as positive controls for the CMhmFw2 and 
CMhmRev2 primers. Water was used as a negative control in each PCR assay. PCR 
products were identified by electrophoresis in a 1.5% agarose gel stained with 
ethidium bromide. Samples presenting faint multiple bands were reamplified under 
the same conditions, with cycle numbers reduced to 20 and using <1µl of amplicon 
from the previous PCR as template. 
PCR products of the expected size were purified with the NucleoSpin® Gel 
and PCR Clean-up kit (MACHEREY NAGEL GmbH & Co.) according to the 
manufacturer’s instructions, quantified with a QubitTM fluorometer (InvitrogenTM) and 
submitted to DNA Sequencing & Services (MRC PPU, College of Life Sciences, 
University of Dundee, Scotland, www.dnaseq.co.uk) for sequencing in the sense and 
antisense directions using Applied Biosystems Big-Dye Ver 3.1 chemistry on an 
Applied Biosystems model 3730 automated capillary DNA sequencer. 
Sequence editing and analysis were performed in MacVector v13.0.3, Inc. 
Reconstruction of near-complete 16S rRNA gene sequences was performed from 
products of either the first or second conventional PCR as follows: the sequences 
derived from the universal 8F and 1492R primers were combined with sequences 
generated from internal primers (HBT-F and HBT-R) as previously published 
(Criado-Fornelio et al., 2003). The sequences derived from the MhfFw2 and 
MhfRev2 primers were combined with sequences generated by the use of additional 
internal primers previously described (Aquino et al., 2014). These newly derived 16S 
rRNA gene sequences were initially compared to sequences available in GenBank 
 8 
using BLAST and were then aligned with 16S rRNA gene sequences from canine 
haemoplasma species available from GenBank using Clustal-W to determine the 
approximate phylogenetic affiliation. 
The 16S rRNA gene sequences from 4/17 Mhc species detected in this study 
were submitted to GenBank under the following accession numbers: KP715857, 
KP715858, KP715859 and KP715860. These sequences were used in phylogenetic 
analysis from the distances matrices using the neighbour-joining method. The dataset 
was resampled 1000 times to generate bootstrap percentage values. 
 
1.2.6 Statistical analysis 
Data were entered into Excel® and statistical evaluation was carried out using 
SPSS for Windows (SPSS Inc., Chicago IL, USA). Results of the generic 
haemoplasma, Mhc and CMhp qPCR assays were tested for association with 
categorical variables (gender, breed, being privately owned or from a breeding 
kennel, clinical status, presence of ticks and ectoparasites prophylaxis) using the χ2 
test. Statistical comparison between Mhc and CMhp prevalence were calculated using 
the χ2 test. The Kolmogorov-Smirnov test was used to test for normal distribution of 
the continuous variables PCV and age, and subsequently the Mann-Whitney U test 
was used to determine whether any significant difference existed between the results 
of the generic, Mhc and CMhp qPCR assays and each of PCV and age. Significance 
was assigned as a P value <0.05.  
 
1.3 Results 
A total of 246 samples were recruited for the study. Categorical descriptive 
data are summarized in Table 1. Age data were available for 245 dogs and ranged 
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from 2 to 9 years (median age: 2 years). All dogs in the study were entire except for 
two neutered male dogs aged 1 and 1.5 years. Two dogs had a history of travelling 
outside of Nigeria (one 4 year old male and a 5 year old female). No dogs were 
splenectomised. Due to the low numbers of neutered, splenectomised and travelled 
dogs, these variables were excluded from statistical analysis. PCV data were available 
for 228 dogs and ranged from 10 to 62% (median PCV: 42%). Of the 245 dogs 
evaluated for the presence of ticks 135 (55,1%) were found to be infected with ticks 
and all of these were identified as Rhipicephalus sanguineus. 
Adequate DNA amplification, as indicated by an internal control GAPDH 
qPCR Ct value of ≤ 26, occurred in 239 samples (median Ct: 15, range 12-26), whilst 
six had no GAPDH qPCR Ct values and had to be re-extracted, after which PCR 
analysis generated Ct values of ≤ 26 (range 12-19) in five of these dogs. In the one 
remaining dog the repeat extract generated a GAPDH qPCR Ct of 34 and was 
therefore excluded from the study. Thus 245 dogs comprised the final study 
population. All positive and negative controls for DNA extraction and qPCRs yielded 
positive and negative results, respectively. 
The species-specific qPCRs found that 18 of 245 (7.3%) dogs were Mhc 
positive (median Ct 27, range 19-44) and one of 245 (0.4%) was CMhp positive (Ct 
43). The Mhc prevalence was significantly higher than CMhp prevalence (p=0.03). 
No dog had concomitant infection with Mhc and CMhp. 
The generic haemoplasma qPCR HF assay was positive alone (i.e. with a 
negative HM assay result) in 27 dogs (median Ct: 37, range 30-44) whilst the HM 
assay was positive alone (i.e. with a negative HF assay result) in two dogs (Cts of 24 
and 39). The generic haemoplasma qPCR HM and HF assays were both positive for 
13 dogs (HF median Ct: 23, range 15-31; HM median Ct: 26, range13-40). The 
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generic haemoplasma qPCR was considered positive in any dog with any positive HF 
and/or HM result; thus 17.1% (42/245) of dogs were positive. 
There was no significant association between positive generic haemoplasma 
qPCR or Mhc qPCR status and any assessed variables, including PCV (Table 1). 
There was no significant association between generic haemoplasma PCR positive 
status nor Mhc PCR positive status and presence of anaemia (Table 1). 
There were 25 dogs with discordant results between the generic haemoplasma 
qPCRs and species-specific qPCRs. Two different conventional PCRs were used to 
try to amplify and sequence the near complete 16S rRNA gene from these discordant 
dogs, but only nine generated visible PCR products with which to attempt sequencing. 
Five out of these nine dogs generated products using primers 8F and 1492R and four 
with primers MhfFw2 and MhfRev2. The other 16 discordant dogs didn’t generate 
any visible PCR products, which was expected considering the high Ct values 
(median Ct: 39, range 33-44) obtained from the generic haemoplasma qPCRs. 
The five 16S rRNA gene sequences generated using primers 8F and 1492R 
revealed two sequences 100% identical to Anaplasma phagocytophilum (KP745629), 
one sequence 99% identical to Anaplasma ovis (KJ410246), one sequence 100% 
identical to Serratia marcescens (KR133281) and one sequence 100% identical to 
Aerococcus spp. (KP943730). The four 16S rRNA gene sequences generated with 
primers MhfFw2 and MhfRev2 showed >99.5% identity with Mhc and Mhf 
worldwide-derived sequences. The phylogenetic tree revealed no obvious 
geographical or host specificity grouping of the Mhc sequences. All four Mhc 
sequences from our study fell within a single clade with other Mhc and Mhf 
sequences (Fig. 1). 
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1.4 Discussion 
This study reports, for the first time, the prevalence of haemoplasma species in 
dogs from Nigeria. The overall prevalence was similar to that found in the south of 
France (Kenny et al., 2004), Spain (Roura et al., 2010) and Tanzania (Barker et al., 
2010), but higher than in Switzerland (Wengi et al., 2008), Greece (Tennant et al., 
2011), Trinidad (Barker et al., 2010), Italy (Novacco et al., 2010) and UK (Warman et 
al., 2010) and lower than in Portugal (Novacco et al., 2010), Sudan (Inokuma et al., 
2006) and Australia (Barker et al., 2012). Considering Mhc infection, Nigerian dogs 
had a similar prevalence to that reported in Trinidad (Barker et al., 2010) and Greece 
(Tennant et al., 2011) but a higher prevalence than dogs from France (Kenny et al., 
2004), Italy (Novacco et al., 2010), Switzerland (Wengi et al., 2008), UK (Warman et 
al., 2010) and Spain (Novacco et al., 2010). Considering CMhp infection, Nigerian 
dogs had a lower prevalence than all previous studies (Barker et al., 2010; Kenny et 
al., 2004; Novacco et al., 2010; Tennant et al., 2011; Warman et al., 2010), except 
from those in Switzerland (Wengi et al., 2008) and Spain (Roura et al., 2010). The 
findings in the previous canine haemoplasma studies from France (Kenny et al., 2004) 
and Sudan (Inokuma et al., 2006) found CMhp to be more prevalent than Mhc, which 
is in contrast to those of the current study and a previous study from Trinidad (Barker 
et al., 2010) where Mhc was significantly (p=0.03, current study) more prevalent than 
CMhp. In agreement with previous studies from Switzerland (Wengi et al., 2008), 
Australia (Hetzel et al., 2012), USA (Compton et al., 2012) and UK (Warman et al., 
2010), our study found no dog infected with more than one haemoplasma species. 
This contrasts with the majority of haemoplasma prevalence studies (Barker et al., 
2010; Kenny et al., 2004; Novacco et al., 2010; Roura et al., 2010; Tennant et al., 
2011), which have found dogs to be co-infected with Mhc and CMhp. 
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The differences in the prevalence of Mhc and CMhp found in previous studies 
compared to those found herein could reflect the dog population sampled. Our study 
primarily comprised privately owned pets with few kennelled dogs and this may have 
contributed to the low prevalence of Mhf and CMhp seen. A previous study 
(Kemming et al., 2004b) assessing haemoplasma infection in pet and kennelled dog 
populations found that kennelled dogs were at high risk of haemoplasma infection 
(35%), which is much higher than the haemoplasma prevalence found herein. One 
study in Australia (Barker et al., 2012), sampling free-roaming dogs, found a higher 
Mhc and CMhp prevalence than studies in pet dogs (Barker et al., 2010; Novacco et 
al., 2010; Roura et al., 2010; Wengi et al., 2008) like ours, although a direct 
comparison cannot be made as there were no data on outdoor access for the dogs in 
the current study. One study performed in dogs from Mediterranean countries found 
that being a crossbred was a risk factor for haemoplasma infection, however the 
majority of the crossbreds in that study lived in kennels, which was also identified as 
a risk factor for canine haemoplasma infection (Novacco et al., 2010; Tennant et al., 
2011); it may well be that the living conditions are more important than breed as a 
risk factor for infection. Also, different dog populations have diverse behaviour 
activities that may be involved in other methods of haemoplasma transmission, such 
as direct inoculation and transplacental infection (Compton et al., 2012). 
Different PCR assays with varying sensitivities may also contribute to the 
differences in canine haemoplasma prevalences reported in studies (Compton et al., 
2012). Poor quality DNA and/or PCR inhibitors can result in false negative PCR 
results and consequently lower prevalences, if the PCR assays don’t incorporate 
internal controls, as used in the current study.  
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Climate may also play a part, with an increased risk of haemoplasma 
infections in warmer countries such as Portugal (Novacco et al., 2010), Sudan 
(Inokuma et al., 2006), Tanzania (Barker et al., 2010) and the south of France (Kenny 
et al., 2004), which may be associated with potential vectors. In our study, the overall 
haemoplasma prevalence was comparable to that found in regions with a similar 
climate, such as the south of France (Kenny et al., 2004), Spain (Roura et al., 2010) 
and Tanzania (Barker et al., 2010). This, in combination with the near significant 
difference in the haemoplasma prevalence between dogs with and without ticks found 
herein (table 1), indicates that ticks may be potential vectors of haemoplasmas. In 
Nigeria, tick-borne pathogens have been previously (Ogo et al., 2012; Reye et al., 
2012) identified in ticks and dogs. In the current study, significance was approached 
for an association between the ectoparasite prophylaxis and haemoplasma infection. 
Previous evidence of an association between the tick Rhipicephalus sanguineus and 
canine haemoplasma infection has been reported (Wengi et al., 2008); dogs infected 
with haemoplasmas in Switzerland had a history of travelling to countries where R. 
sanguineus is found. A Mediterranean study also documented an association between 
exposure to ticks and canine haemoplasma infection (Novacco et al., 2010). However, 
another study (Barker et al., 2010) failed to find a similar association, although it must 
be remembered that haemoplasmas can cause chronic infections and so recent tick 
exposure may not be apparent. Additionally, the mode of transmission of canine 
haemoplasmas in the field is uncertain (Barker et al., 2010). 
There was no significant association between canine haemoplasma infection 
and age in our study, as has been reported previously (Barker et al., 2010; Kenny et 
al., 2004; Tennant et al., 2011; Wengi et al., 2008). One previous study (Barker et al., 
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2010) found that males were more likely to be Mhc positive than females, and in the 
current study significance was approached for gender and Mhc infection. 
No significant association was found between haemoplasma status and either 
PCV or the presence of anaemia, in accordance with previous studies (Barker et al., 
2010; Hetzel et al., 2012; Novacco et al., 2010; Roura et al., 2010). This finding could 
be due to chronic haemoplasma infection in dogs (Kemming et al., 2004a; Messick et 
al., 2002; Wengi et al., 2008) or the mild pathogenicity of Mhc and CMhp in most 
infected dogs (Compton et al., 2012). One study tracked haemoplasma infected dogs 
and showed that, despite continuous PCR positive results, no anaemia occurred 
(Wengi et al., 2008). Additional factors, such as immunosuppression and 
splenectomy, are usually necessary to induce overt disease in haemoplasma-infected 
dogs (Novacco et al., 2010; Warman et al., 2010), and none of the dogs in our study 
were known to have such factors. 
Cytological examination of blood smears were originally included in the 
study, however an ‘Eperythrozoon species-like’ parasite was the only organism 
thought to be seen on a blood smear from a single dog that was negative in all 
haemoplasmas PCRs. Yet, the observation of organisms on erythrocytes in blood 
smears is known to be unreliable in the diagnosis of haemoplasma infections, as PCR 
is the gold standard whilst cytology has been reported to have a sensitivity of 0 to 
37,5% and specificity of 84 to 98% (Jensen et al. 2001; Westfall et al. 2001; Tasker et 
al. 2003a and Bauer et al. 2008), therefore cytological data did not warrant inclusion 
in the final study. 
Eleven of the 13 dogs positive in both generic haemoplasma qPCR assays 
(HM and HF) had lower Cts for the HF assay compared to the HM assay, most likely 
indicating infection with a haemoplasma species in the haemofelis group as 
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previously reported (Tasker et al., 2010), whilst two dogs had lower Ct values for the 
HM assay compared to the HF assay, most likely indicating infection with a 
haemoplasma species in the haemominutum group (Tasker et al., 2010). 
Twenty-five dogs were positive by the generic haemoplasma qPCR assays but 
negative by the haemoplasma species-specific qPCRs. The 16S rRNA gene sequences 
from four of these dogs revealed that they were identical to M. haemocanis. The 
samples that were Mhc on sequencing had low haemoplasma copy numbers (Cts > 
30), which may be the reason for the discordant results. In five of the 25 discordant 
dogs, sequencing results revealed close identity of 16S rRNA gene sequences with 
non-haemoplasma species: two dogs were infected with Anaplasma phagocytophilum, 
which, with Anaplasma platys, is one of the canine anaplasmosis agents (Beall et al., 
2008); one dog was infected with Anaplasma ovis, a species known to infect sheep 
(Giangaspero et al., 2015) but not yet reported in dogs; one dog was infected with 
Serratia marcescens, an opportunistic agent known to cause nosocomial infection in 
dogs (Lobetti et al., 2002; Perez et al., 2011) and one dog was infected with 
Aerococcus sp., recently reported to cause resistant urinary infection in one dog 
(Budreckis et al., 2015). These findings may indicate that the generic haemoplasma 
qPCRs can detect bacteria other than haemoplasmas and illustrates the importance of 
sequencing in animals yielding positive results with generic PCR assays. However it 
is possible that haemoplasma co-infections were present in these dogs but that the 
universal 16S rRNA gene PCR amplified other co-infections (e.g. Anaplasma spp.) 
present at higher levels in the blood. We felt that the use of generic haemoplasma 
PCRs was important to evaluate the possibility of infection with novel haemoplasma 
species with sequence differences affecting the primer and/or probe binding in the 
species-specific qPCRs. Attempts to amplify and sequence the 16S rRNA gene in the 
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remaining 16 discordant samples failed, so it is possible that other bacterial species or 
novel haemoplasma species were present in these samples, as previously reported (Hii 
et al., 2012; Varanat et al., 2011), but at a level too low to allow amplification with 
both conventional PCR assays. 
The partial 16S rRNA gene Mhc sequences generated in our study showed no 
genetic variability compared to other Mhc sequences from dogs in different countries 
(Novacco et al., 2010; Tasker et al., 2003b) and they grouped with them on 
phylogenetic analysis (Fig. 1). Phylogenetic analysis showed the canine haemoplasma 
species to group into two distinct clades; one clade compromising CMhm and CMhp 
species, and the other consisting of Mhc and Mhf species, as reported previously 
(Tasker et al., 2003b). The newly derived Nigerian Mhc sequences from the present 
study showed >99.6% identity with sequences previously reported for Mhc and Mhf 
(Kenny et al., 2004; Messick et al., 2002). A similar result, in which Mhc and Mhf 
16S rRNA gene sequences shared >99% identity, has been previously reported 
(Brinson and Messick, 2001). However, phylogenetic studies based on the RNase P 
RNA gene showed that Mhc is a distinct species infecting the dog (do Nascimento et 
al., 2012). Unfortunately further phylogenetic analysis was not possible in the current 
study as insufficient haemoplasma DNA was available from these dogs for further 
amplification studies. 
The current study represents the first report of the prevalence of canine 
haemoplasmas in dogs from Nigeria together with near complete 16S rRNA gene 
sequencing for Mhc in a number of dogs. The latter found very little evidence of 
genetic variability with other Mhc species. 
 
1.5 Conclusion 
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In conclusion, the overall prevalence of haemoplasma species from dogs in 
Nigeria was comparable to other countries with a similar warm climate. Close genetic 
identity exists among 16S rRNA gene sequences from worldwide Mhc species. No 
association with anaemia reinforces the likely low pathogenicity of the canine 
haemoplasma species. 
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Table 1. Characteristics of Nigerian dogs and haemoplasma PCR status 
 
§ P value indicates χ2 test for categorical variables, Mann-Whitney U test for 
continuous variables.  
* All ticks found were identified as Rhipicephalus sanguineus 
 
  
Variable 
No. of dogs (%) (for categorical variables) or Median (range) (for continuous variables) 
Total 
N (%) 
Generic 
haemoplasma 
qPCR 
positive 
Generic 
haemoplasma 
qPCR 
negative 
P 
value 
Mhc qPCR 
positive 
Mhc qPCR 
negative 
P value 
Gender             245 (100%) 
Male 103 (42.3%) 21 (50%) 82 (40.7%) 
0.173 
12 (66.7%) 91 (40.6%) 
>0.05 
Female 142 (57.7%) 21 (50%) 121 (59.3%) 6 (33.3%) 136 (59.4%) 
Breed               210 (100%) 
Purebred 37 (17,6%) 3 (7.7%) 34 (19.8%) 
0.071 
1 (5.6%) 36 (18.8%) 
0.20 
Crossbred 173 (82.3%) 36 (92.3%) 137 (80.2%) 17 (94.4%) 156 (81.2%) 
Privately owned or 
breeding kennel origin 245 (100%) 
Privately 
owned  
218 (89%) 38 (90.5%) 180 (88.6%) 
0.312 
18 (100%) 200 (89%) 
0.38 
Breeding 
kennel 
27 (11%) 4 (9.5%) 23 (11.3%) 0 27 (11%) 
Clinical status    245 (100%) 
Healthy 85 (34.6%) 13 (31%) 72 (35.3%) 
0.722 
4 (22.2%) 81 (35.5%) 
0.31 
Sick 160 (65.4%) 29 (69%) 131 (64.7%) 14 (77.8%) 146 (64.5%) 
Presence of ticks*   245 (100%) 
Yes 135 (55.1%) 29 (69%) 106 (52.5%) 
0.061 
13 (72.2%) 122 (53.9%) 
0.14 
No 110 (44.9%) 13 (31%) 97 (47.5%) 5 (27.8%) 105 (46.1%) 
Ectoparasite prophylaxis   245 (100%) 
Yes 193 (78.5%) 31 (73.8%) 162 (79.4%) 
0.415 
11 (61.1%) 182 (79.8%) 
0.076 
No 52 (21.5%) 11 (26.2%) 41 (20.6%) 7 (38.9%) 45 (20.2%) 
Age (years)  1 (2-6) 2 (2-9) 0.320 1 (2-4) 2 (2-9) 0.188 
Packed Cell 
Volume 
(PCV) (%) 
 38 (14-57) 43 (10-62) 0.131 36 (15-52) 43 (10-62) 0.095 
Presence of anaemia 
Anaemic 70 (30.7%) 13 (29.5%) 57 (30.2%) 
0.700 
5 (31.3%) 64 (30.8%) 
1.0 Non 
anaemic 
158 (69.3%) 31 (70.5%) 132 (69.8%) 11 (68.8%) 144 (69.2%) 
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Figure 1. Phylogenetic relations of previously published haemoplasma species 16S 
rRNA gene sequences and Mhc sequences from Nigerian dogs. Bootstrap percentage 
values are given at the nodes of the phylogenetic tree (only values >700 are shown). 
Evolutionary distances are to the scales shown. Clostridium spp. was used as an out-
group. GenBank accession numbers are indicated in the figure. Mhc sequences (F2, 
G7, H7 and E8. GenBank nucleotide accession numbers: KP715857, KP715858, 
KP715859 and KP715860 respectively) were generated in the current study. Mhc = 
Mycoplasma haemocanis, CMhp = “Candidatus Mycoplasma haematoparvum”, Mhf 
= Mycoplasma haemofelis, CMhm = “Candidatus Mycoplasma haemominutum”. 
 
 
